Tag: Flu
Recombinant Vaccine Confers More Protection Against Influenza
High-dose recombinant vaccine more effective than egg-based standard-dose vaccine among adults aged 50 to 64
Variability Seen in Use of Influenza Antiviral Agents in Children
Guideline-concordant antiviral use low for young children at high risk for influenza complications
Coadministration of COVID-19, Influenza Vaccines Seems Effective
Generally similar effectiveness against COVID-19 and seasonal influenza-related outcomes seen with coadministration
At-Home, Inhaled Flu Vaccine Could Be on Horizon
Research has shown that people older than 18 can use the nasal spray vaccine when given instructions without any additional guidance
Severity of Flu Season Was High for Children, Teens in 2022 to 2023
Lower proportion of children, teens hospitalized with influenza during 2022 to 2023 season were vaccinated versus previous years
IDSA: Wastewater Surveillance Allows Monitoring of Viral Infections
Positive correlation seen for composite influenza A virus signal with weekly confirmed clinical cases
Flu Shots Up for Children in States With Vaccine Mandate
Those living in a state with a vaccine mandate during 2020 to 2021 flu season had higher probability of receiving flu shot
In Early Trial, Results Promising for Moderna Combo COVID-Flu Vaccine
Moderna hopes to get federal regulatory approval for the combined vaccine in 2025
Immune Response Not Inferior With Coadministration of COVID-19, Flu Shots
Similar immune response and no increase in rate of reactogenicity events seen with coadministration versus COVID-19 vaccine alone
Flu Vaccine Cut Risk for Influenza-Linked Hospitalizations in 2023
Interim data show vaccine effectiveness of 51.9 percent in five South American countries during their flu season
